Webseite switt.ch

Date, Location and General Information

Note: The number of participants is limited.

Workshop Topic and Objectives

The valuation of technologies and development projects is a major task of people responsible for in- or out-licensing at universities or companies. The same is true for people dealing with the creation and management of spin-off or start-up companies. This workshop addresses fundamental aspects on valuation and shows relevant instruments which can be applied. It is an introductory course to company and product licensing valuation. The main focus will be on life sciences although the basic principles apply to any sector.

Participants will learn the basics of valuation and the main factors used in the valuation process. They will understand the commonly used valuation methods and their limitations and will be able to apply the relevant instruments. Moreover, they will practice the valuation process in the context of case studies. The information about the case studies will be provided ahead of the workshop and attendees are expected to prepare the cases.

Target Audience

Professionals working at universities or in companies who are responsible for in- or out-licensing and have practical experience in drafting and negotiating licenses. Other professionals who need to understand the key aspects of the valuation process such as people working in business development or general management.

Speaker

Dr. Patrik Frei is founder and CEO of Venture Valuation AG, Switzerland. Venture Valuation specializes in independent, third party assessment and valuation of emerging high growth companies in such as biotechnology/life sciences, high-tech and ICT. Further more, Venture Valuation runs Biotechgate (www.biotechgate.com), a global Biotechnology and Life Sciences Database.

Patrik graduated from the Business University of St. Gall and wrote his dissertation about ”Assessment and valuation of high growth companies” at the Swiss Federal Institute of Technology, EPFL Lausanne. His previous occupations include CFO of a logistic company and training at several international corporations: LeCroy (Geneva, New York), Hans Merensky Holding (South Africa), Swatch Group - EM Microelectronic (Marin). Patrik is also a board member and founder of ineo, a holding company of the Swiss dental implant VC-backed firm Thommen Medical and Ophthalmopharma a Swiss based biotech ophthalmology company. He has published numerous articles including in Nature Biotechnology, Chimia and contributions in “Starting a Business in the Life Sciences: From Idea to Market” and “Building Biotechnology: Starting, Managing, and Understanding Biotechnology Companies”. Patrik gives lectures at Seoul National University, South Korea; Danube University Krems, Austria; Trinity College Dublin; ETHZ and EPFL, Switzerland and presented at numerous Valuation workshops around the world. In 2009, Patrik was named as one of the 20 most influential people in the Swiss Life Sciences Industry by Bilan, a Swiss Business Journal. (www.venturevaluation.com)

Agenda